Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Oct 5 - Oct 10
106.4 Development and Validation of the Postoperative Recovery Assessment in Lung Cancer (PRA_Lung): A Modular Patient-Reported Outcome Measure Cheng Lei 1 , Hongfan Yu 2 , Wen Zhou 2 , Qiuling Shi 2 1 Sichuan Cancer Hospital and Institute, Chengdu, China, 2 State Key Laboratory of Ultrasound in Medicine and Engineering, Chongqing Medical University, Chongqing, China Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :106.4 Aims This study aimed to develop and validate a modular patient-reported outcome measure (PROM) for assessing postoperative recovery in lung cancer patients, integrating symptom burden and functional interference domains while prioritizing patient-centered perspectives
State-licensed pharmacies under section 503A of the FD&C Act were protected from enforcement actions for 60 days
The medication targets GLP-1, GIP, and glucagon receptors
Fox Foundation and connect patients with professional medical support through Healthcare.pro
US$ 20.64
US$ 21.13
US$ 28.21
US$ 20.47
US$ 26.89
US$ 23.23
%20powder-1.png)
US$ 20.46
US$ 23.54
US$ 26.51
